Antituberculous drugs in pregnancy.
D000014:Abnormalities, Drug-Induced / Q000453:epidemiology; D000818:Animals; D000995:Antitubercular Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D051381:Rats; D012293:Rifampin / Q000009:adverse effects; D012306:Risk; D014376:Tuberculosis / Q000188:drug therapy*
D000995:Antitubercular Agents; D012293:Rifampin